Federated Hermes, Inc. Gilead Sciences, Inc. Transaction History
Federated Hermes, Inc.
- $50.2 Billion
- Q2 2025
A detailed history of Federated Hermes, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 2,980,646 shares of GILD stock, worth $358 Million. This represents 0.66% of its overall portfolio holdings.
Number of Shares
2,980,646
Previous 4,866,310
38.75%
Holding current value
$358 Million
Previous $545 Million
39.39%
% of portfolio
0.66%
Previous 1.24%
Shares
32 transactions
Others Institutions Holding GILD
# of Institutions
2,320Shares Held
1.02BCall Options Held
11.8MPut Options Held
9.11M-
Black Rock Inc. New York, NY121MShares$14.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.3 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.1 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.56 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.5 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $150B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...